A Singularity in mRNA Virus, Virology, and Vaccinology

S. Niggol Seo

Chapter Chapter 6 in The Economics of Singularities of Science Elucidated with Buddhist Thoughts, 2024, pp 117-138 from Springer

Abstract: Abstract This chapter explores a singularity in virology—the science of viruses—and vaccinology—the science of vaccines. Relying on the recent experience of the COVID-19 pandemic from 2020 to 2023, it explains the SARS-CoV-2 virus, which is an mRNA virus, and the mRNA vaccines. The SARS-CoV-2 virus has killed 7 million people worldwide and infected 800 million people by the end of 2023. The mRNA vaccine is a novel vaccine in which only genetic instructions are contained, unlike the traditional Pasteur vaccine which is a weakened virus. About 6–7 billion doses of the two mRNA vaccines, the Pfizer’s Comirnaty and the Moderna’s Spikevax, were administered during the pandemic. It is remarkable that there has been continuing disputes over the origin of the virus. Although the virology is a natural progression of microbiological and biological science, a singularity risk may arise when the origin of a super virus cannot be discovered. The mechanism of such may involve subsequent wars and distrust among nations. From the standpoint of a singularity risk, it is important to make the virology research transparent to the public and it is vital to locate the origin of the virus as early as possible once a virus is identified.

Keywords: Virology; Vaccinology; COVID-19 pandemic; SARS-CoV-2 virus; mRNA vaccine; Traditional vaccine; Origin of the virus; Singularity risk (search for similar items in EconPapers)
Date: 2024
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-031-69118-8_6

Ordering information: This item can be ordered from
http://www.springer.com/9783031691188

DOI: 10.1007/978-3-031-69118-8_6

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().